Z satysfakcją informujemy o dokonaniu strategicznej inwestycji w spółkę Intelliseq, wiodącego dostawcę zaawansowanych rozwiązań w obszarze analizy danych genetycznych i genomiki. Vinci S.A., wraz z grupą inwestorów prywatnych i instytucjonalnych, przeprowadziło rundę finansowania o wartości 19 milionów złotych. Brawo Aleksander Kłósek Paweł Pałasz, ktorzy z ramienia YouNick Mint opiekowali sie procesem.
🧬 How many of the 7 000+ genetic diseases, including rare diseases, can we effectively treat with the help of genetic diagnostics? 🔍 In how many patients with lung, breast, ovarian or other cancers does genomic analysis allow for more effective, personalized treatment? ❤️ How can we improve the therapeutic pathway for cardiovascular disease through individual genetic loads like familial hypercholesterolemia and genetic cardiomyopathies? 🔬 These are difficult questions to answer simply and for the moment, it is still challenging to assess the importance and scale of genomics from the perspective of the possibilities it brings in terms of treatment, prevention, and individualized decision-making for an aware and fulfilling life. 🚀 I am convinced that we only scratched the surface in the middle of the third decade of exploring the possibilities of full genome sequencing. Certainly, the role of genetic testing will grow intensively - and with it, exponentially, the amount of data needed to be analysed, interpreted and aggregated in a form that will support professionals to work effectively with all relevant insights. 🔥 I am super-exited, that an active participant in this trend is Intelliseq, which has just secured funding of 💰PLN 19 m from Vinci S.A. and a group of recognised private and institutional investors The investment will enable Intelliseq to expand its sales in the US 🇺🇸 and European 🇪🇺 markets and work on developing a cutting-edge solution in the area of polymodal genetic prediction. I also sincerely hope that awareness of the cutting-edge #iFlow solutions provided by Intelliseq will also foster innovations in the genetic field among polish 🇵🇱 laboratories, clinics, and healthcare institutions. 🎉 Huge congratulations and, above all, further success for the founding team: Klaudia Szklarczyk-Smolana, Marcin Piechota, Slawomir Golda, Michal Korostynski. 🙏 I would like to thank all parties to the transaction: the new investors, the existing shareholders, and the advisors who supported the process: Luiza Nowacka, Tomasz Serwan, Jan Ćwiek, Monika Prokopowicz, Adrianna Kłoda-Szczesna, Bartosz Drabikowski, Adam Żelezik Executive MBA, Piotr Woliński, Marcin Adamczyk, Bank Gospodarstwa Krajowego, Tadeusz Wesołowski Ph.D., Marcin Sadlej, Tomasz Jędrzejczak, Jakub Skałbania, Dominik Herberholz, Krzysztof Choma, Magdalena Surowiec, Jakub Sitarz, Unfold.vc, Jakub Kapica, Maciej Wasilewski, Emilia Mierzejewska, Brysiewicz, Bokina i Wspólnicy , Paweł Pałasz, Rafał Roszak, Dagmara Nickel. 💡 As YouNick Mint, together with a group of private investors, we have supported Intelliseq since our investment in October 2022.